| Primary |
| Drug Use For Unknown Indication |
41.2% |
| Pollakiuria |
23.5% |
| Angina Pectoris |
5.9% |
| Benign Prostatic Hyperplasia |
5.9% |
| Hypertension |
5.9% |
| Hypertonic Bladder |
5.9% |
| Insomnia |
5.9% |
| Neurogenic Bladder |
5.9% |
|
| Iiird Nerve Paralysis |
16.7% |
| Parkinson's Disease |
16.7% |
| Delirium |
8.3% |
| Haemorrhage Subcutaneous |
8.3% |
| Idiopathic Thrombocytopenic Purpura |
8.3% |
| Ileus |
8.3% |
| Lip Disorder |
8.3% |
| Mesenteric Occlusion |
8.3% |
| Platelet Count Decreased |
8.3% |
| Purpura |
8.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
21.7% |
| Anxiety |
20.0% |
| Neurogenic Bladder |
15.0% |
| Parkinsonism |
10.0% |
| Parkinson's Disease |
6.7% |
| Delusion |
5.0% |
| Obesity |
5.0% |
| Depression |
3.3% |
| Hypertension |
3.3% |
| Hypoaesthesia |
3.3% |
| Osteoporosis |
3.3% |
| Gastritis |
1.7% |
| Pollakiuria |
1.7% |
|
| Tremor |
33.3% |
| Parkinson's Disease |
22.2% |
| Withdrawal Syndrome |
22.2% |
| Ileus |
11.1% |
| Thrombocytopenia |
11.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.2% |
| Parkinson's Disease |
11.7% |
| Prophylaxis |
7.3% |
| Neurogenic Bladder |
6.5% |
| Hypertension |
5.6% |
| Prostate Cancer Stage Iv |
5.6% |
| Insomnia |
5.4% |
| Constipation |
4.4% |
| Pollakiuria |
4.0% |
| Multiple Sclerosis |
3.8% |
| Gastritis |
3.5% |
| Benign Prostatic Hyperplasia |
3.3% |
| Anxiety |
2.9% |
| Osteoporosis |
2.7% |
| Interstitial Lung Disease |
2.3% |
| Relapsing-remitting Multiple Sclerosis |
2.1% |
| Back Pain |
1.9% |
| Dementia Alzheimer's Type |
1.9% |
| Dysuria |
1.9% |
| Infection |
1.9% |
|
| White Blood Cell Count Increased |
15.4% |
| Death |
7.7% |
| Tremor |
7.7% |
| White Blood Cell Count Decreased |
7.7% |
| Loss Of Consciousness |
6.4% |
| Platelet Count Decreased |
5.1% |
| Pneumonia |
5.1% |
| Renal Failure Acute |
5.1% |
| Fall |
3.8% |
| Hallucination |
3.8% |
| Inappropriate Antidiuretic Hormone Secretion |
3.8% |
| Retinal Vein Occlusion |
3.8% |
| Urinary Tract Infection |
3.8% |
| Urine Output Decreased |
3.8% |
| Wound Complication |
3.8% |
| Anaemia |
2.6% |
| Cardiac Failure |
2.6% |
| Convulsion |
2.6% |
| Hypoglycaemia |
2.6% |
| Injection Site Haemorrhage |
2.6% |
|
| Interacting |
| Neurogenic Bladder |
57.1% |
| Diabetes Mellitus |
21.4% |
| Hypertension |
21.4% |
|
|
